Please use this identifier to cite or link to this item: http://223.31.159.10:8080/jspui/handle/123456789/747
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Sushil-
dc.contributor.authorKumari, Renu-
dc.contributor.authorPandey, Richa-
dc.contributor.authorSharma, Vishakha-
dc.date.accessioned2017-05-22T10:17:23Z-
dc.date.available2017-05-22T10:17:23Z-
dc.date.issued2017-
dc.identifier.citationProceedings of the Indian National Science Academy, 83(1): 103-149en_US
dc.identifier.issn2454-9983-
dc.identifier.urihttp://59.163.192.83:8080/jspui/handle/123456789/747-
dc.descriptionAccepted date: 20 October 2016en_US
dc.description.abstractEbola virus disease (EVD) is a highly lethal contagious disease caused by the negative RNA strand Ebola virus. Reservoired in wild forest animals of Africa, Ebola virus infects humans that come in direct contact of diseased animals and outbreaks of EVD result from person to person spread of infection. A recent EVD outbreak in West Africa has killed several thousand persons. Since Ebola infection will persist in animals, EVD epidemics are expected to continue to occur in future. Infected travellers from Africa can initiate/import outbreaks in countries of other continents. This review describes the properties of the Ebola virus and EVD, the ongoing attempts to develop diagnostics, vaccines and medicines for prevention and cure of EVD and the supportive care that saves some EVD patients. Also discussed are measures that can stop and prevent EVD outbreaks. Need for inclusion of EVD in the education, research, drug and medical equipment manufacturing programmes, of the densly populated countries such as India, is emphasised.en_US
dc.description.sponsorshipGrateful thanks are due towards Indian National Science Academy for the grant of an INSA emeritus scientistship to SK and to Director of National Institute of Plant Genome Research and Director of Indian Institute of Chemical Technology for facilities, and to the virologists AC Banerjea of National Institute of Immunology and RK Saxena of South-Asian University for reading the draft of the manuscript and making useful suggestions for its improvement.en_US
dc.language.isoen_USen_US
dc.publisherIndian National Science Academyen_US
dc.subjectAnti-Ebola Therapeutics/Vaccinesen_US
dc.subjectCytokine Stormen_US
dc.subjectEbolavirus Diseaseen_US
dc.subjectEbola Geneticsen_US
dc.subjectFilovirusen_US
dc.subjectRepurposed Drugsen_US
dc.titleEbola virus disease: Biology, diagnosis, treatment and prevention of epidemicsen_US
dc.typeArticleen_US
dc.identifier.officialurlhttp://www.insajournals.in/insaj/index.php/proceedings/article/view/291en_US
dc.identifier.doi10.16943/ptinsa/2017/41286en_US
Appears in Collections:Institutional Publications

Files in This Item:
File Description SizeFormat 
Kumar S_2017_1.pdf1.03 MBAdobe PDFThumbnail
View/Open


Items in IR@NIPGR are protected by copyright, with all rights reserved, unless otherwise indicated.